[Radio-induced breast morphoea: an unrecognized complication]

Cancer Radiother. 2014 Jan;18(1):64-7. doi: 10.1016/j.canrad.2013.09.006. Epub 2013 Dec 3.
[Article in French]

Abstract

Morphoea is a localized scleroderma. Since the 1990s, it is described as a complication after irradiation for breast cancer. This complication is unrecognized and underdiagnosed. Irradiation seems to be a factor inducing an autoimmune process. Clinicians should be aware in case of an erythema in a treated area, appearing on average one year after the end of the irradiation. Histology alone can prove the diagnosis and rule out differential diagnoses: principally mastitis (carcinomatous, infectious), chronic radiodermatitis or radiation recall. Treatment of this rare complication is not consensual; it is most often topical steroids. The evolution is marked by a gradual decrease from the initial inflammation. Sclerosis persists, more or less substantially.

Keywords: Breast; Complication; Morphoea; Morphée; Radiotherapy; Radiothérapie; Sein; Side-effect.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimetabolites / therapeutic use
  • Autoantibodies / blood
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / etiology*
  • Autoimmune Diseases / pathology
  • Autoimmune Diseases / therapy
  • Breast Diseases / diagnosis
  • Breast Diseases / etiology*
  • Breast Diseases / pathology
  • Breast Diseases / therapy
  • Breast Neoplasms / radiotherapy*
  • Debridement
  • Disease Progression
  • Erythema / etiology
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Phototherapy
  • Radiodermatitis / diagnosis
  • Radiodermatitis / etiology
  • Radiodermatitis / pathology
  • Radiodermatitis / therapy
  • Scleroderma, Localized / diagnosis
  • Scleroderma, Localized / etiology*
  • Scleroderma, Localized / pathology
  • Scleroderma, Localized / therapy

Substances

  • Anti-Bacterial Agents
  • Antimetabolites
  • Autoantibodies
  • Immunosuppressive Agents